But having a strong, effective national advocate in APC requires more than goodwill or talk.
It requires funding. It requires investment in our work that goes beyond the dues you or your pharmacy pays.
We’re looking out over the next three quarters of 2023 and already seeing new challenges pop up that we must be equipped—funded—to tackle: Proposed compounding restrictions in California, the likelihood FDA will move to restrict compounded hormones, and more.
So yeah, this is an ask for money. It’s a plea for you to walk the talk.
OneFund is what fuels our entire advocacy operation. You can invest in it here.
CompPAC is how we support members of Congress who think like you do about your compounding profession. It needs your investment, too. Do that here.
I won’t belabor it, and I won’t tell you how much to invest. Just INVEST. It’s the only way we’ll be able to protect your profession.
— Anthony
P.S. Read on for this week’s news – oh, and pay attention to all the upcoming webinars. Lots of good stuff ahead.
Anthony Grzib is VP of quality and compliance, state-regulated pharmacies at Wedgewood Pharmacy in Swedesboro, New Jersey. You can reach him at agrzib@wedgewoodpharmacy.com.
|